The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...
The FDA has approved the first new class of schizophrenia drug in 70 years Australian science contributed to the discovery of ...
The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication ...
FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug Administration ...
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...
The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.
US regulators have approved a new treatment for schizophrenia, the first of its kind targeting the mental condition in ...
A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.
A slew of legal and procedural processes are expected to play out ahead of Jospeh Corcoran’s scheduled execution on Dec. 18.
By Lola Fadulu The drugs, which resembled real pharmaceuticals ... Lawyers for Mayor Eric Adams of New York filed a 25-page memo arguing that the conduct described in the indictment against ...